^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Colon Cancer
    Drug:5-fluorouracil (Thymidylate synthase inhibitor) +
    irinotecan (Topoisomerase I inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    01/30/2020
    Excerpt:
    CAMPTOSAR is a topoisomerase inhibitor indicated for...First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum.
    Secondary therapy:
    leucovorin calcium